Cytek Biosciences, Inc. CTKB Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Cytek Biosciences, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s cash ratio?
- Cytek Biosciences, Inc. (CTKB) reported cash ratio of 0.4× in Q1 2026.
- How has Cytek Biosciences, Inc.'s cash ratio changed year-over-year?
- Cytek Biosciences, Inc.'s cash ratio decreased by 72.1% year-over-year, from 1.4× to 0.4×.
- What is the long-term trend for Cytek Biosciences, Inc.'s cash ratio?
- Over 5 years (2020 to 2025), Cytek Biosciences, Inc.'s cash ratio has grown at a -43.1% compound annual growth rate (CAGR), from 6.2× to 0.4×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.